eamdacademy.org-Eqog-1792347396-j419680571 1792347396 Eurasian Academy of Medicine and Dentistry info@eamdacademy.org Eurasian Academy of Medicine and Dentistry Journal of Applied Pharmaceutical Technologies and Systems J Appl Pharm Technol Syst 3149-9589 2025 4 2 Chen Hao Liu Fang Zhao Lin 2025 10.68159/j419680571 https://eamdacademy.org/pub/journal/3/article/j419680571 Ravinetto R, Pinxten W, Rägo L. Quality of medicines in resource-limited settings: need for ethical guidance. Glob Bioeth. 2018;29(1):81-4. Mackintosh M, Tibandebage P, Njeru MK, Kungu JK, Israel C, Mujinja PG. Rethinking health sector procurement as developmental linkages in East Africa. Soc Sci Med. 2018;200:182-9. Ozawa S, Evans DR, Bessias S, Haynie DG, Yemeke TT, Laing SK, et al. Prevalence and estimated economic burden of substandard and falsified medicines in low-and middle-income countries: a systematic review and meta-analysis. JAMA Netw Open. 2018;1(4):e181662. Bianchi C, Bianco M, Ardanche M, Schenck M. Healthcare frugal innovation: a solving problem rationale under scarcity conditions. Technol Soc. 2017;51:74-80. Bhatti YA, Prime M, Harris M, Wadge H, McQueen J, Patel H, et al. The search for the holy grail: frugal innovation in healthcare from low-income or middle-income countries for reverse innovation to developed countries. BMJ Innov. 2017;3(2). Hindocha CN, Antonacci G, Barlow J, Harris M. Defining frugal innovation: a critical review. BMJ Innov. 2021;7(4). Dabić M, Obradović T, Vlačić B, Sahasranamam S, Paul J. Frugal innovations: a multidisciplinary review & agenda for future research. J Bus Res. 2022;142:914-29. Roth L, Nalim A, Turesson B, Krech L. Global landscape assessment of screening technologies for medicine quality assurance: stakeholder perceptions and practices from ten countries. Global Health. 2018;14(1):43. Vickers S, Bernier M, Zambrzycki S, Fernandez FM, Newton PN, Caillet C. Field detection devices for screening the quality of medicines: a systematic review. BMJ Glob Health. 2018;3(4):e000905. Harrison RP, Ruck S, Medcalf N, Rafiq QA. Decentralized manufacturing of cell and gene therapies: overcoming challenges and identifying opportunities. Cytotherapy. 2017;19(10):1140-51. Seoane-Viano I, Xu X, Ong JJ, Teyeb A, Gaisford S, Campos-Álvarez A, et al. A case study on decentralized manufacturing of 3D printed medicines. Int J Pharm X. 2023;5:100184. Roth L, Bempong D, Babigumira JB, Banoo S, Cooke E, Jeffreys D, et al. Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems. Global Health. 2018;14(1):102. Caillet C, Vickers S, Zambrzycki S, Luangasanatip N, Vidhamaly V, Boutsamay K, et al. Multiphase evaluation of portable medicines quality screening devices. PLoS Negl Trop Dis. 2021;15(9):e0009287. Harrison RP, Ruck S, Rafiq QA, Medcalf N. Decentralised manufacturing of cell and gene therapy products: learning from other healthcare sectors. Biotechnol Adv. 2018;36(2):345-57. Schiavetti B, Wynendaele E, Melotte V, Van der Elst J, De Spiegeleer B, Ravinetto R. A simplified checklist for the visual inspection of finished pharmaceutical products: a way to empower frontline health workers in the fight against poor-quality medicines. J Pharm Policy Pract. 2020;13(1):9. Caillet C, Vickers S, Zambrzycki S, Fernández FM, Vidhamaly V, Boutsamay K, et al. A comparative field evaluation of six medicine quality screening devices in Laos. PLoS Negl Trop Dis. 2021;15(9):e0009674. Chakravarty S. Resource constrained innovation in a technology intensive sector: frugal medical devices from manufacturing firms in South Africa. Technovation. 2022;112:102397. Englezos K, Wang L, Tan EC, Kang L. 3D printing for personalised medicines: implications for policy and practice. Int J Pharm. 2023;635:122785. Tracy T, Wu L, Liu X, Cheng S, Li X. 3D printing: innovative solutions for patients and pharmaceutical industry. Int J Pharm. 2023;631:122480. Caillet C, Vickers S, Vidhamaly V, Boutsamay K, Boupha P, Zambrzycki S, et al. Evaluation of portable devices for medicine quality screening: lessons learnt, recommendations for implementation, and future priorities. PLoS Med. 2021;18(9):e1003747. Waffo Tchounga CA, Sacré PY, Ravinetto R, Lieberman M, Hamuli Ciza P, Ngono Mballa R, et al. Usefulness of medicine screening tools in the frame of pharmaceutical post-marketing surveillance. PLoS One. 2023;18(8):e0289865. Sacre PY, Tchounga CA, De Bleye C, Hubert P, Marini RD, Ziemons E. White analytical chemistry evaluation of medicines quality screening devices in low-and middle-income countries field settings. Green Anal Chem. 2024;11:100158. Corsini L, Dammicco V, Moultrie J. Frugal innovation in a crisis: the digital fabrication maker response to COVID‐19. R&D Manag. 2021;51(2):195-210. Bicudo E, Brass I. Institutional and infrastructure challenges for hospitals producing advanced therapies in the UK: the concept of ‘point-of-care manufacturing readiness’. Regen Med. 2022;17(10):719-37. Smith DM, Kapoor Y, Klinzing GR, Procopio AT. Pharmaceutical 3D printing: design and qualification of a single step print and fill capsule. Int J Pharm. 2018;544(1):21-30. Lafeber I, Tichem JM, Ouwerkerk N, Van Unen AD, Van Uitert JJ, Bijleveld-Olierook HC, et al. 3D printed furosemide and sildenafil tablets: innovative production and quality control. Int J Pharm. 2021;603:120694. Jose PA, GV PC. 3D printing of pharmaceuticals – a potential technology in developing personalized medicine. Asian J Pharm Res Dev. 2018;6(3):46-54. Gnegel G, Hauk C, Neci R, Mutombo G, Nyaah F, Häfele-Cahab A, et al. Identification of falsified chloroquine tablets in Africa at the time of the COVID-19 pandemic. Am J Trop Med Hyg. 2020;103(1):73-6.